Menu
Annual · values202520242023202220212020
Operating Cash Flow-18.20 M USD-17.95 M USD-17.65 M USD-2.66 M USD-3.24 M USD
Depreciation & Amortization302000 USD173000 USD133000 USD75000 USD
Stock-Based Compensation657000 USD562000 USD1.57 M USD
Capital Expenditures179000 USD980000 USD153000 USD218000 USD
Cash Flow from Investing-179000 USD-980000 USD-153000 USD1.12 M USD-425.00 M USD
Cash Flow from Financing16.63 M USD20.20 M USD21.84 M USD1.50 M USD428.37 M USD
Dividends Paid1.82 M USD2.45 M USD
Stock Buybacks
Free Cash Flow-18.38 M USD-18.93 M USD-17.81 M USD-2.88 M USD

Envoy Medical, Inc. operates in the healthcare sector, specifically focusing on the design and development of innovative medical devices aimed at improving hearing healthcare. The company's flagship products are designed to provide advanced solutions for individuals experiencing hearing loss through cutting-edge technology that enhances auditory performance. Envoy Medical, Inc. is known for leveraging its expertise to improve patient outcomes and deliver a better quality of life for those with hearing impairments. Positioned within the broader medical device industry, Envoy impacts various healthcare sub-sectors, including audiology and otolaryngology. Through its dedication to research and development, the company plays a significant role in pushing the boundaries of what is possible in hearing health technologies. Its contributions are important for both patients and healthcare providers, offering novel solutions that integrate seamlessly into medical practices worldwide. With a commitment to innovation, Envoy Medical, Inc. continues to be a key player in the transformation of auditory healthcare, striving to address the needs of a growing demographic requiring sophisticated hearing aid solutions.